Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Brettler

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 30, 2014
Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassayB Boylan, A S Rice, A L Dunn, et al.
The Journal of Infectious Diseases|November 24, 1999
Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohortT C Greenough, D B Brettler, F Kirchhoff, et al.
American Journal of Hematology|August 1, 1991
Hepatocellular carcinoma in hemophiliaM Colombo, P M Mannucci, D B Brettler, et al.
Vox Sanguinis|January 1, 1991
Haemophilia in the 1990s: report of a joint meeting of the World Health Organization and World Federation of HemophiliaC K Kasper, P M Mannucci, V Bulyzhenkov, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Hemophilia in the 1990s: principles of management and improved access to careC K Kasper, P M Mannucci, V Bulyzhenkov, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Blood|July 15, 1992
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter studyD B Brettler, P M Mannucci, A Gringeri, et al.
Transfusion|February 1, 1992
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator GroupP M Mannucci, K Schimpf, T Abe, et al.
Blood|April 15, 1992
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivoK A Bauer, P M Mannucci, A Gringeri, et al.
The New England Journal of Medicine|December 27, 1990
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study GroupR S Schwartz, C F Abildgaard, L M Aledort, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|October 30, 2014
Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassayB Boylan, A S Rice, A L Dunn, et al.
The Journal of Infectious Diseases|November 24, 1999
Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohortT C Greenough, D B Brettler, F Kirchhoff, et al.
American Journal of Hematology|August 1, 1991
Hepatocellular carcinoma in hemophiliaM Colombo, P M Mannucci, D B Brettler, et al.
Vox Sanguinis|January 1, 1991
Haemophilia in the 1990s: report of a joint meeting of the World Health Organization and World Federation of HemophiliaC K Kasper, P M Mannucci, V Bulyzhenkov, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Hemophilia in the 1990s: principles of management and improved access to careC K Kasper, P M Mannucci, V Bulyzhenkov, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Blood|July 15, 1992
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter studyD B Brettler, P M Mannucci, A Gringeri, et al.
Transfusion|February 1, 1992
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator GroupP M Mannucci, K Schimpf, T Abe, et al.
Blood|April 15, 1992
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivoK A Bauer, P M Mannucci, A Gringeri, et al.
The New England Journal of Medicine|December 27, 1990
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study GroupR S Schwartz, C F Abildgaard, L M Aledort, et al.
Pageof 6